Mutations which severely affect the function of the outer membrane of Escherichia coli and Salmonella typhimurium (lpxA4 and firA mutations of lipid A synthesis and rfaE mutation of the lipopolysaccharide inner-core synthesis) were found to decrease the MICs of erythromycin, roxithromycin, clarithromycin, and azithromycin by factors of 32 to 512, 32 to 1,024, 64 to 512, and 16 to 64, respectively. The sensitization factors for three other hydrophobic antibiotics (rifampin, fusidic acid, and mupirocin) ranged from 16 to 300. The outer membrane permeability-increasing agents polymyxin B nonapeptide (3 ,ug/ml) and deacylpolymyxin B (1 ,ug/ml) sensitized wild-type E. coli to azithromycin by factors of 10 and 30, respectively. Quantitatively very similar sensitization to the other macrolides took place. Polymyxin-resistant pmrA mutants of S. typhimurium displayed no cross-resistance to azithromycin. Proteus mirabilis mutants which were sensitized to polymyxin by a factor of .300 to .1,000 had a maximal two-to fourfold increase in sensitivity to azithromycin. These 
The outer membrane (OM) of gram-negative bacteria acts as a relatively effective permeability barrier against all hydrophobic antibiotics, including erythromycin (8, 9) . Therefore, erythromycin has only very limited use in the treatment of gram-negative infections. On the other hand, the newer macrolides clarithromycin and azithromycin have increased activity against several gram-negative bacterial species (4, 7, 10) . This could suggest that they penetrate the OM better than erythromycin. The present communication assesses the role of the OM as a resistance factor to these antibiotics by using (i) bacterial mutants which have drastically altered OM permeability barrier function (mutants supersusceptible to hydrophobic antibiotics and mutants resistant or supersusceptible to polycations) as well as (ii) agents which permeabilize the OM.
OM-defective, antibiotic-supersusceptible mutants included those which produce a heptose-deficient lipopolysaccharide (LPS) (strain D21f2 of Eschenichia coli and strain SL1102 of Salmonella typhimunium [17, 18] ) and those which are thermosensitive for growth and defective in the synthesis of the lipid A component of the LPS (the firA mutants of E. coli and S. typhimurium as well as the lpxA mutant of E. coli [3, 16, 17] ). The MICs were determined by broth microdilution method in L broth as described previously (16 wild-type enteric bacteria to erythromycin and other hydrophobic antibiotics by factors of 10 to 1,000 (12) , and as shown in Table 2 , they sensitized the wild-type E. coli (IH3080 [14] Why then is azithromycin more active than erythromycin against bacteria such as E. coli and S. typhimurium? Azithromycin hardly diffuses significantly better than erythromycin through the unspecific and hydrophilic porin channels (1), even though this has not yet been tested. On the other hand, erythromycin, roxithromycin, and clarithromycin are monobasic whereas azithromycin is a dication. Since for E. coli SC9252 (the polymyxin-resistant variant described by Meyers et al. [6] the polymyxin B MIC is 64-fold higher and the azithromycin MIC is 4-fold higher but the erythromycin MIC is only 2-fold higher than the MICs for its parent strain, it has been suggested (1, 2) that azithromycin interacts with the acidic LPS and penetrates the OM by virtue of this interaction, in analogy to the pentacationic antibiotics of the polymyxin family.
The hypothesis was reevaluated by studying the azithromycin susceptibility of the well-characterized polymyxin- (Table 3) . Even though wild-type P. mirabilis is known to be very resistant to azithromycin (7, 10), heptosedeficient R45 was susceptible. Its mutants, which were sensitized to polymyxin by a factor of >300 to 1,000, displayed a maximal two-to fourfold increase in susceptibility to azithromycin and a twofold increase in susceptibility to erythromycin (Table 3) . When all the results shown in Table  3 were combined, the difference between the MICs of erythromycin and azithromycin was 16-to 32-fold for all polymyxin-resistant strains and 32-fold for all polymyxinsusceptible strains. This could suggest that the enhanced activity of azithromycin over that of erythromycin may not be mediated by any putative electrostatic binding to LPS. 
